Swedish private‑equity giant EQT is testing a foothold in Asia‑Pacific venture and growth capital after closing a record‑size flagship fundraise. The firm now runs a single‑manager account (early‑stage SMA) for a limited partner focused on early‑stage technology and med‑tech deals across the region in 2024. Co‑heads Hari Gopalakrishnan and Nicholas Macksey say the SMA serves as a proof‑of‑concept for a dedicated strategy.

The SMA targets startups that can scale within Asia’s rapidly expanding digital health and AI ecosystems, where capital inflows have surged in recent years. By limiting exposure to a single LP, EQT can fine‑tune its investment thesis without committing its broader fund resources. Success would give the firm leverage to launch a full‑blown regional fund and compete with established local players for future.

Investors watch the experiment closely, as EQT’s move signals broader private‑equity interest in Asia’s early‑stage landscape after a year of record fundraising in Europe. If the SMA delivers attractive returns, the firm could allocate a sizable portion of its next fund to the region, reshaping deal flow and potentially raising competition for limited‑partner capital in the market.